CVS is reportedly reviewing its options - including a possible breakup
By Bill Peters
Drugstore chain says it is 'continually exploring ways to create shareholder value'
Drugstore chain CVS Health Corp. in recent weeks has been reviewing its options as a company - among them a potential breakup - the Wall Street Journal reported on Monday.
The Journal said that CVS's (CVS) board had tapped bankers in connection with the evaluation process, but that no decision had been made, and that the review could end without any significant modifications to the company.
"CVS Health's management team and board of directors are continually exploring ways to create shareholder value," a company representative said when reached for comment.
"We remain focused on driving performance and delivering high-quality healthcare products and services enabled by our unmatched scale and integrated model," the statement continued.
The Journal reported the news as CVS tries to rethink its physical pharmacies, cutting its staff and store count and pivoting more toward health services, as drugstore profitability wanes.
Earlier Monday, the Journal reported that Glenview Capital Management, a hedge fund and big investor in the chain, planned to meet CVS executives to discuss ways to revive the company's financials.
Shares of CVS were up 2.9% after hours on Monday, after finishing 2.4% higher during regular trading. As of the close of Monday's trading, the stock was down 9.8% over the past 12 months.
-Bill Peters
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-30-24 1943ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks